Key result
The walking distance test provides diagnostic, prognostic, and therapeutic utility for assessing functional status and predicting disease course in patients with heart failure.
Why the study?
Early diagnosis, appropriate therapy, and effective disease control improve HF prognosis, and recent research highlights new potential for the 6MWT to interpret and predict disease course.
Answers are grounded in this paper and cite their sources.
The 6-minute walk test is a valuable tool for assessing functional status, prognosis, and therapeutic response in patients with heart failure.
The six-minute walk test (6MWT) is a well-known exercise test used in medical practice to assess the functional status of patients with various chronic cardiovascular and respiratory diseases. The results of modern research describe new potential of 6MWT, which allow a more accurate interpretation and predict the course of diseases. Heart failure (HF) is the outcome of many structural and functional heart disorders. To improve the prognosis of patients with HF, early diagnosis, appropriate therapy and effective control of the disease course are important components. This review describes the diagnostic, prognostic and therapeutic potential of 6MWT in patients with HF.
No takes yet. Share an insight, caveat, or question.
Budnevsky et al. (2020) conducted a review in Heart failure. 6-minute walk test (6MWT) was evaluated. The walking distance test provides diagnostic, prognostic, and therapeutic utility for assessing functional status and predicting disease course in patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: